

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thyroid hormone generation (GO:0006590) | 8.64601650 |
| 2 | sarcomere organization (GO:0045214) | 7.98687635 |
| 3 | cardiac myofibril assembly (GO:0055003) | 7.23495486 |
| 4 | thyroid hormone metabolic process (GO:0042403) | 6.90185472 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.59602779 |
| 6 | myofibril assembly (GO:0030239) | 6.42974788 |
| 7 | cardiac muscle contraction (GO:0060048) | 5.98521479 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.97440874 |
| 9 | plasma membrane repair (GO:0001778) | 5.92193137 |
| 10 | regulation of actin filament-based movement (GO:1903115) | 5.72307931 |
| 11 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.62308518 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 5.46898045 |
| 13 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.44981335 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.44551004 |
| 15 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.44191477 |
| 16 | cardiac muscle cell development (GO:0055013) | 5.34637099 |
| 17 | muscle filament sliding (GO:0030049) | 5.27860576 |
| 18 | actin-myosin filament sliding (GO:0033275) | 5.27860576 |
| 19 | adult heart development (GO:0007512) | 5.20100228 |
| 20 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.19890891 |
| 21 | cardiac cell development (GO:0055006) | 5.02769526 |
| 22 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.98507413 |
| 23 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.97115074 |
| 24 | actomyosin structure organization (GO:0031032) | 4.94277132 |
| 25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.91216461 |
| 26 | regulation of relaxation of muscle (GO:1901077) | 4.89823808 |
| 27 | heart trabecula formation (GO:0060347) | 4.88520364 |
| 28 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.88439464 |
| 29 | carnitine shuttle (GO:0006853) | 4.86183015 |
| 30 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.82762307 |
| 31 | postsynaptic membrane organization (GO:0001941) | 4.77915244 |
| 32 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.77300800 |
| 33 | cell communication involved in cardiac conduction (GO:0086065) | 4.72971575 |
| 34 | cardiac muscle hypertrophy (GO:0003300) | 4.52368585 |
| 35 | striated muscle contraction (GO:0006941) | 4.50655267 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 4.45839029 |
| 37 | neuron recognition (GO:0008038) | 4.45434348 |
| 38 | regulation of the force of heart contraction (GO:0002026) | 4.44893564 |
| 39 | axonal fasciculation (GO:0007413) | 4.42810351 |
| 40 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.40582791 |
| 41 | actin-mediated cell contraction (GO:0070252) | 4.38682655 |
| 42 | regulation of skeletal muscle contraction (GO:0014819) | 4.35764751 |
| 43 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.33113551 |
| 44 | regulation of striated muscle contraction (GO:0006942) | 4.32946718 |
| 45 | regulation of sarcomere organization (GO:0060297) | 4.31788076 |
| 46 | muscle tissue morphogenesis (GO:0060415) | 4.31568372 |
| 47 | striated muscle hypertrophy (GO:0014897) | 4.26781923 |
| 48 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.16656906 |
| 49 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.14806638 |
| 50 | behavioral response to nicotine (GO:0035095) | 4.12172115 |
| 51 | cell migration in hindbrain (GO:0021535) | 4.11792442 |
| 52 | cerebral cortex radially oriented cell migration (GO:0021799) | 4.11371476 |
| 53 | regulation of membrane repolarization (GO:0060306) | 4.08553238 |
| 54 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.06599153 |
| 55 | cell communication by electrical coupling (GO:0010644) | 4.02062480 |
| 56 | regulation of cell communication by electrical coupling (GO:0010649) | 3.97667972 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 3.97595693 |
| 58 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.96200548 |
| 59 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.93565710 |
| 60 | neuronal ion channel clustering (GO:0045161) | 3.87752891 |
| 61 | dendritic spine morphogenesis (GO:0060997) | 3.87580581 |
| 62 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.87382326 |
| 63 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.83721147 |
| 64 | regulation of cardiac muscle contraction (GO:0055117) | 3.78668954 |
| 65 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.77808220 |
| 66 | muscle hypertrophy (GO:0014896) | 3.76499760 |
| 67 | NADH metabolic process (GO:0006734) | 3.74675152 |
| 68 | nucleobase catabolic process (GO:0046113) | 3.74337920 |
| 69 | presynaptic membrane assembly (GO:0097105) | 3.74167837 |
| 70 | synaptic vesicle exocytosis (GO:0016079) | 3.72750074 |
| 71 | neuron cell-cell adhesion (GO:0007158) | 3.71246076 |
| 72 | cardiac muscle cell action potential (GO:0086001) | 3.71061936 |
| 73 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.70828335 |
| 74 | establishment of mitochondrion localization (GO:0051654) | 3.70504745 |
| 75 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.69796252 |
| 76 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.68870040 |
| 77 | protein localization to synapse (GO:0035418) | 3.68624003 |
| 78 | oxygen transport (GO:0015671) | 3.68245528 |
| 79 | regulation of coenzyme metabolic process (GO:0051196) | 3.68095418 |
| 80 | regulation of cofactor metabolic process (GO:0051193) | 3.68095418 |
| 81 | neuronal action potential propagation (GO:0019227) | 3.67939927 |
| 82 | presynaptic membrane organization (GO:0097090) | 3.64974900 |
| 83 | negative regulation of potassium ion transport (GO:0043267) | 3.64594720 |
| 84 | carnitine transmembrane transport (GO:1902603) | 3.62405599 |
| 85 | aspartate family amino acid catabolic process (GO:0009068) | 3.61457117 |
| 86 | heart process (GO:0003015) | 3.60948529 |
| 87 | heart contraction (GO:0060047) | 3.60948529 |
| 88 | synaptic vesicle maturation (GO:0016188) | 3.59908638 |
| 89 | response to parathyroid hormone (GO:0071107) | 3.58429138 |
| 90 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.58404948 |
| 91 | regulation of heart rate (GO:0002027) | 3.53600318 |
| 92 | relaxation of cardiac muscle (GO:0055119) | 3.52154032 |
| 93 | auditory behavior (GO:0031223) | 3.52100749 |
| 94 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.47621866 |
| 95 | regulation of heart contraction (GO:0008016) | 3.42877701 |
| 96 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.41121494 |
| 97 | positive regulation of cation channel activity (GO:2001259) | 3.38977781 |
| 98 | glutamate secretion (GO:0014047) | 3.38109574 |
| 99 | lysine catabolic process (GO:0006554) | 3.38016831 |
| 100 | lysine metabolic process (GO:0006553) | 3.38016831 |
| 101 | actin filament-based movement (GO:0030048) | 3.37703020 |
| 102 | regulation of ATPase activity (GO:0043462) | 3.37456225 |
| 103 | regulation of ATP catabolic process (GO:1903289) | 3.37456225 |
| 104 | regulation of sequestering of triglyceride (GO:0010889) | 3.36762976 |
| 105 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.36483586 |
| 106 | layer formation in cerebral cortex (GO:0021819) | 3.36286186 |
| 107 | central nervous system myelination (GO:0022010) | 3.35311386 |
| 108 | axon ensheathment in central nervous system (GO:0032291) | 3.35311386 |
| 109 | regulation of cardioblast differentiation (GO:0051890) | 3.35242389 |
| 110 | regulation of synapse structural plasticity (GO:0051823) | 3.34203743 |
| 111 | carnitine transport (GO:0015879) | 3.33049152 |
| 112 | amino-acid betaine transport (GO:0015838) | 3.33049152 |
| 113 | thyroid gland development (GO:0030878) | 3.32654797 |
| 114 | transmission of nerve impulse (GO:0019226) | 3.32480456 |
| 115 | regulation of fatty acid oxidation (GO:0046320) | 3.31710259 |
| 116 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.28181091 |
| 117 | cardiac muscle adaptation (GO:0014887) | 3.28093415 |
| 118 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.28093415 |
| 119 | muscle hypertrophy in response to stress (GO:0003299) | 3.28093415 |
| 120 | cardiac conduction (GO:0061337) | 3.25599904 |
| 121 | positive regulation of heart contraction (GO:0045823) | 3.25000883 |
| 122 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.23067506 |
| 123 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.22351346 |
| 124 | locomotory exploration behavior (GO:0035641) | 3.22022105 |
| 125 | negative regulation of protein localization to cell surface (GO:2000009) | 3.22000590 |
| 126 | positive regulation of synapse maturation (GO:0090129) | 3.19814368 |
| 127 | creatine metabolic process (GO:0006600) | 3.18587741 |
| 128 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.17803299 |
| 129 | synaptic transmission, cholinergic (GO:0007271) | 3.16975885 |
| 130 | synaptic transmission, glutamatergic (GO:0035249) | 3.16420332 |
| 131 | axon extension (GO:0048675) | 3.16118288 |
| 132 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.15031011 |
| 133 | venous blood vessel morphogenesis (GO:0048845) | 3.14615311 |
| 134 | positive regulation of heart rate (GO:0010460) | 3.14604020 |
| 135 | oxaloacetate metabolic process (GO:0006107) | 3.13569987 |
| 136 | mechanosensory behavior (GO:0007638) | 3.10921933 |
| 137 | spinal cord development (GO:0021510) | 3.10629340 |
| 138 | fatty acid beta-oxidation (GO:0006635) | 3.08261259 |
| 139 | regulation of sulfur metabolic process (GO:0042762) | 3.07638108 |
| 140 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.07536318 |
| 141 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.07016731 |
| 142 | mitochondrion transport along microtubule (GO:0047497) | 3.07016731 |
| 143 | head development (GO:0060322) | 3.04789312 |
| 144 | vocalization behavior (GO:0071625) | 3.01960305 |
| 145 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.99300041 |
| 146 | neuron projection extension (GO:1990138) | 2.98593417 |
| 147 | positive regulation of dendritic spine development (GO:0060999) | 2.98504805 |
| 148 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.96834327 |
| 149 | retinal ganglion cell axon guidance (GO:0031290) | 2.96460108 |
| 150 | cerebral cortex neuron differentiation (GO:0021895) | 2.93971000 |
| 151 | protein localization to cilium (GO:0061512) | 2.93418503 |
| 152 | synapse assembly (GO:0007416) | 2.91744031 |
| 153 | cell-cell junction maintenance (GO:0045217) | 2.90580870 |
| 154 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.89824295 |
| 155 | axon extension involved in axon guidance (GO:0048846) | 2.89236381 |
| 156 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.89236381 |
| 157 | central nervous system neuron axonogenesis (GO:0021955) | 2.87180791 |
| 158 | response to auditory stimulus (GO:0010996) | 2.86809662 |
| 159 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.86451616 |
| 160 | neurotransmitter secretion (GO:0007269) | 2.86198425 |
| 161 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.85786240 |
| 162 | neuron fate determination (GO:0048664) | 2.83579422 |
| 163 | spinal cord association neuron differentiation (GO:0021527) | 2.80722901 |
| 164 | neurofilament cytoskeleton organization (GO:0060052) | 2.79107258 |
| 165 | neuromuscular synaptic transmission (GO:0007274) | 2.78519695 |
| 166 | membrane depolarization during action potential (GO:0086010) | 2.78447923 |
| 167 | positive regulation of synapse assembly (GO:0051965) | 2.76847970 |
| 168 | exploration behavior (GO:0035640) | 2.76774362 |
| 169 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.74263795 |
| 170 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.73272899 |
| 171 | dendritic spine organization (GO:0097061) | 2.70249544 |
| 172 | regulation of synapse maturation (GO:0090128) | 2.68810501 |
| 173 | regulation of respiratory system process (GO:0044065) | 2.68797602 |
| 174 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.66163933 |
| 175 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.65767455 |
| 176 | snRNA transcription (GO:0009301) | 2.65216487 |
| 177 | cell junction maintenance (GO:0034331) | 2.64345209 |
| 178 | ganglion development (GO:0061548) | 2.63602095 |
| 179 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.62429024 |
| 180 | neuron-neuron synaptic transmission (GO:0007270) | 2.62186166 |
| 181 | glutamate receptor signaling pathway (GO:0007215) | 2.60977272 |
| 182 | gamma-aminobutyric acid transport (GO:0015812) | 2.60823304 |
| 183 | brain morphogenesis (GO:0048854) | 2.58034553 |
| 184 | dendrite morphogenesis (GO:0048813) | 2.58006429 |
| 185 | cellular potassium ion homeostasis (GO:0030007) | 2.56060772 |
| 186 | short-term memory (GO:0007614) | 2.55414052 |
| 187 | regulation of axon guidance (GO:1902667) | 2.54328439 |
| 188 | cranial nerve morphogenesis (GO:0021602) | 2.53391347 |
| 189 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.52080763 |
| 190 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.49219631 |
| 191 | camera-type eye morphogenesis (GO:0048593) | 2.49188535 |
| 192 | synaptic vesicle endocytosis (GO:0048488) | 2.48482538 |
| 193 | positive regulation of membrane potential (GO:0045838) | 2.48055223 |
| 194 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.47622069 |
| 195 | membrane depolarization (GO:0051899) | 2.47447216 |
| 196 | negative regulation of axon extension (GO:0030517) | 2.45576597 |
| 197 | synapse organization (GO:0050808) | 2.45537607 |
| 198 | adult walking behavior (GO:0007628) | 2.45425726 |
| 199 | positive regulation of dendrite morphogenesis (GO:0050775) | 2.44841973 |
| 200 | nephron tubule morphogenesis (GO:0072078) | 2.43122456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.36243379 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.69502998 |
| 3 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.68163488 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.45487172 |
| 5 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 3.23656608 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.20304002 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.20304002 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95534244 |
| 9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.89831161 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.85507036 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.72942482 |
| 12 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.59961312 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.59072047 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.54338592 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.53285397 |
| 16 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.52489696 |
| 17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.49780674 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.42340922 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.37841494 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.36998559 |
| 21 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.36335407 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.35128836 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28365973 |
| 24 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.25210377 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.19949979 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.17914188 |
| 27 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17248777 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.15950225 |
| 29 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.09965427 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.06179337 |
| 31 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06080441 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.03855305 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.02169356 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.00506227 |
| 35 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.00339828 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.00213160 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.97959858 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.97883950 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95402813 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.89689850 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.88296982 |
| 42 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.86371703 |
| 43 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.81115352 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74754400 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62631556 |
| 46 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.62334135 |
| 47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.60148347 |
| 48 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.59888593 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.58335259 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55913705 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50299489 |
| 52 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.49429209 |
| 53 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.49340546 |
| 54 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.49260555 |
| 55 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.48910355 |
| 56 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.48123844 |
| 57 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.48013585 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47703986 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44741058 |
| 60 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.43233881 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41294339 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40824674 |
| 63 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.39136278 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35146274 |
| 65 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.34609413 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34208752 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33229015 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31824347 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31741697 |
| 70 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.31532624 |
| 71 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.29714017 |
| 72 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.28430994 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.28285826 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27119811 |
| 75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26397321 |
| 76 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.25880251 |
| 77 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25656737 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25235431 |
| 79 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24825040 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22576974 |
| 81 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20767238 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20348147 |
| 83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17851158 |
| 84 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.16952827 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11805192 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10835261 |
| 87 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10804664 |
| 88 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.10615197 |
| 89 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10065449 |
| 90 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.09525357 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08155695 |
| 92 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07119300 |
| 93 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06760959 |
| 94 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.06320717 |
| 95 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06009178 |
| 96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05929525 |
| 97 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.05598870 |
| 98 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05446199 |
| 99 | P68_20966046_ChIP-Seq_HELA_Human | 1.04899846 |
| 100 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.04128124 |
| 101 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.04128124 |
| 102 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03937050 |
| 103 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.02494296 |
| 104 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.02415972 |
| 105 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02051463 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01524429 |
| 107 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01524429 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01309650 |
| 109 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.01089995 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00809791 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00703768 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00477145 |
| 113 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00153851 |
| 114 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.99930355 |
| 115 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99836849 |
| 116 | GATA1_22025678_ChIP-Seq_K562_Human | 0.99643231 |
| 117 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99387752 |
| 118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99083395 |
| 119 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98269462 |
| 120 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97794134 |
| 121 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.96385548 |
| 122 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.96325607 |
| 123 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96161253 |
| 124 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95555558 |
| 125 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94958635 |
| 126 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94865676 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94434603 |
| 128 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94257303 |
| 129 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93794358 |
| 130 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.93564353 |
| 131 | AR_19668381_ChIP-Seq_PC3_Human | 0.92845934 |
| 132 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92647536 |
| 133 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92564479 |
| 134 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92368987 |
| 135 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.91858172 |
| 136 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.90930806 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90601567 |
| 138 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.90153938 |
| 139 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.90103217 |
| 140 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.89581247 |
| 141 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89125560 |
| 142 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.89017901 |
| 143 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87886289 |
| 144 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87606902 |
| 145 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.87165117 |
| 146 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.87048865 |
| 147 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86719450 |
| 148 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.86696531 |
| 149 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86296126 |
| 150 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86036934 |
| 151 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.85907925 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85707011 |
| 153 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.85498917 |
| 154 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85426404 |
| 155 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84696577 |
| 156 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.83949915 |
| 157 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83227489 |
| 158 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82789163 |
| 159 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.82469394 |
| 160 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82454680 |
| 161 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.81993232 |
| 162 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.80416547 |
| 163 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.79582143 |
| 164 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.79029093 |
| 165 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.77828557 |
| 166 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 0.76942359 |
| 167 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.76423481 |
| 168 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.75653134 |
| 169 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75343985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.71164846 |
| 2 | MP0004084_abnormal_cardiac_muscle | 5.90344487 |
| 3 | MP0003646_muscle_fatigue | 5.39133690 |
| 4 | MP0004215_abnormal_myocardial_fiber | 4.78386921 |
| 5 | MP0000751_myopathy | 4.62265521 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.24376318 |
| 7 | MP0005330_cardiomyopathy | 3.81538810 |
| 8 | MP0000749_muscle_degeneration | 3.19436826 |
| 9 | MP0000778_abnormal_nervous_system | 3.11928641 |
| 10 | MP0003880_abnormal_central_pattern | 3.02189236 |
| 11 | MP0002972_abnormal_cardiac_muscle | 2.95171292 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.84744349 |
| 13 | MP0004087_abnormal_muscle_fiber | 2.83797514 |
| 14 | MP0003137_abnormal_impulse_conducting | 2.77480656 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.69166611 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.65906622 |
| 17 | MP0005385_cardiovascular_system_phenoty | 2.61479767 |
| 18 | MP0001544_abnormal_cardiovascular_syste | 2.61479767 |
| 19 | MP0004270_analgesia | 2.60016040 |
| 20 | MP0006138_congestive_heart_failure | 2.54909607 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.51402257 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.50711889 |
| 23 | MP0005620_abnormal_muscle_contractility | 2.45424049 |
| 24 | MP0004484_altered_response_of | 2.43871127 |
| 25 | MP0000750_abnormal_muscle_regeneration | 2.36939046 |
| 26 | MP0006292_abnormal_olfactory_placode | 2.32828754 |
| 27 | MP0004130_abnormal_muscle_cell | 2.20794486 |
| 28 | MP0003828_pulmonary_edema | 2.18480601 |
| 29 | MP0002063_abnormal_learning/memory/cond | 2.17578795 |
| 30 | MP0002106_abnormal_muscle_physiology | 2.17337532 |
| 31 | MP0002735_abnormal_chemical_nociception | 2.11866954 |
| 32 | MP0003122_maternal_imprinting | 2.11177235 |
| 33 | MP0004510_myositis | 2.10796448 |
| 34 | MP0005499_abnormal_olfactory_system | 2.09872005 |
| 35 | MP0005394_taste/olfaction_phenotype | 2.09872005 |
| 36 | MP0004085_abnormal_heartbeat | 2.09131344 |
| 37 | MP0002734_abnormal_mechanical_nocicepti | 2.06721332 |
| 38 | MP0002269_muscular_atrophy | 2.05873800 |
| 39 | MP0003787_abnormal_imprinting | 1.96160871 |
| 40 | MP0002064_seizures | 1.85248581 |
| 41 | MP0008789_abnormal_olfactory_epithelium | 1.84679551 |
| 42 | MP0009745_abnormal_behavioral_response | 1.84679338 |
| 43 | MP0009379_abnormal_foot_pigmentation | 1.83443859 |
| 44 | MP0002272_abnormal_nervous_system | 1.82450056 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.81296420 |
| 46 | MP0002736_abnormal_nociception_after | 1.78622827 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.74143410 |
| 48 | MP0005369_muscle_phenotype | 1.73051553 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.72411754 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.71549892 |
| 51 | MP0001968_abnormal_touch/_nociception | 1.71228165 |
| 52 | MP0000955_abnormal_spinal_cord | 1.70518287 |
| 53 | MP0002184_abnormal_innervation | 1.69584187 |
| 54 | MP0000747_muscle_weakness | 1.68166936 |
| 55 | MP0001984_abnormal_olfaction | 1.67094697 |
| 56 | MP0001486_abnormal_startle_reflex | 1.65461528 |
| 57 | MP0002557_abnormal_social/conspecific_i | 1.65428033 |
| 58 | MP0000566_synostosis | 1.64835173 |
| 59 | MP0000049_abnormal_middle_ear | 1.64728590 |
| 60 | MP0000759_abnormal_skeletal_muscle | 1.64050793 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 1.62084003 |
| 62 | MP0002733_abnormal_thermal_nociception | 1.60057161 |
| 63 | MP0002882_abnormal_neuron_morphology | 1.59332569 |
| 64 | MP0001970_abnormal_pain_threshold | 1.58626328 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.57271473 |
| 66 | MP0002127_abnormal_cardiovascular_syste | 1.57004317 |
| 67 | MP0003221_abnormal_cardiomyocyte_apopto | 1.55309474 |
| 68 | MP0004233_abnormal_muscle_weight | 1.54107696 |
| 69 | MP0004811_abnormal_neuron_physiology | 1.51802678 |
| 70 | MP0004043_abnormal_pH_regulation | 1.50374224 |
| 71 | MP0005670_abnormal_white_adipose | 1.50295259 |
| 72 | MP0009046_muscle_twitch | 1.49276630 |
| 73 | MP0000534_abnormal_ureter_morphology | 1.48714610 |
| 74 | MP0002653_abnormal_ependyma_morphology | 1.47283487 |
| 75 | MP0003121_genomic_imprinting | 1.46571468 |
| 76 | MP0002067_abnormal_sensory_capabilities | 1.42669334 |
| 77 | MP0005165_increased_susceptibility_to | 1.39999752 |
| 78 | MP0002822_catalepsy | 1.39719594 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.35093218 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.35036209 |
| 81 | MP0002152_abnormal_brain_morphology | 1.33195043 |
| 82 | MP0002752_abnormal_somatic_nervous | 1.32899423 |
| 83 | MP0001440_abnormal_grooming_behavior | 1.32690231 |
| 84 | MP0004142_abnormal_muscle_tone | 1.32603716 |
| 85 | MP0006072_abnormal_retinal_apoptosis | 1.32078880 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 1.30391324 |
| 87 | MP0004885_abnormal_endolymph | 1.30253673 |
| 88 | MP0005551_abnormal_eye_electrophysiolog | 1.29486686 |
| 89 | MP0001529_abnormal_vocalization | 1.29176663 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 1.28777023 |
| 91 | MP0003942_abnormal_urinary_system | 1.24182034 |
| 92 | MP0003861_abnormal_nervous_system | 1.22343674 |
| 93 | MP0005386_behavior/neurological_phenoty | 1.22082791 |
| 94 | MP0004924_abnormal_behavior | 1.22082791 |
| 95 | MP0002234_abnormal_pharynx_morphology | 1.19018809 |
| 96 | MP0003136_yellow_coat_color | 1.18337054 |
| 97 | MP0003950_abnormal_plasma_membrane | 1.16918882 |
| 98 | MP0001299_abnormal_eye_distance/ | 1.16669724 |
| 99 | MP0001879_abnormal_lymphatic_vessel | 1.16493803 |
| 100 | MP0000681_abnormal_thyroid_gland | 1.16325479 |
| 101 | MP0000026_abnormal_inner_ear | 1.15359133 |
| 102 | MP0008569_lethality_at_weaning | 1.14334358 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 1.12560482 |
| 104 | MP0008877_abnormal_DNA_methylation | 1.12523101 |
| 105 | MP0003938_abnormal_ear_development | 1.12388499 |
| 106 | MP0003123_paternal_imprinting | 1.11141506 |
| 107 | MP0003890_abnormal_embryonic-extraembry | 1.10246316 |
| 108 | MP0000343_altered_response_to | 1.10004916 |
| 109 | MP0002066_abnormal_motor_capabilities/c | 1.08915691 |
| 110 | MP0000266_abnormal_heart_morphology | 1.07764375 |
| 111 | MP0001963_abnormal_hearing_physiology | 1.07351517 |
| 112 | MP0010030_abnormal_orbit_morphology | 1.05077795 |
| 113 | MP0004742_abnormal_vestibular_system | 1.02735521 |
| 114 | MP0001188_hyperpigmentation | 1.02491130 |
| 115 | MP0004133_heterotaxia | 1.01247617 |
| 116 | MP0002249_abnormal_larynx_morphology | 1.01223090 |
| 117 | MP0003385_abnormal_body_wall | 1.00620422 |
| 118 | MP0003879_abnormal_hair_cell | 1.00013564 |
| 119 | MP0000678_abnormal_parathyroid_gland | 0.98732202 |
| 120 | MP0004185_abnormal_adipocyte_glucose | 0.97674414 |
| 121 | MP0003279_aneurysm | 0.97013158 |
| 122 | MP0005646_abnormal_pituitary_gland | 0.94885737 |
| 123 | MP0005195_abnormal_posterior_eye | 0.93416230 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.92771777 |
| 125 | MP0002116_abnormal_craniofacial_bone | 0.91217063 |
| 126 | MP0005623_abnormal_meninges_morphology | 0.87686093 |
| 127 | MP0005375_adipose_tissue_phenotype | 0.86027418 |
| 128 | MP0002128_abnormal_blood_circulation | 0.85384672 |
| 129 | MP0002751_abnormal_autonomic_nervous | 0.85360963 |
| 130 | MP0002909_abnormal_adrenal_gland | 0.85309059 |
| 131 | MP0001501_abnormal_sleep_pattern | 0.85261756 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.85084766 |
| 133 | MP0005085_abnormal_gallbladder_physiolo | 0.82195404 |
| 134 | MP0010386_abnormal_urinary_bladder | 0.81026184 |
| 135 | MP0006035_abnormal_mitochondrial_morpho | 0.80667967 |
| 136 | MP0003634_abnormal_glial_cell | 0.80548226 |
| 137 | MP0005377_hearing/vestibular/ear_phenot | 0.78790992 |
| 138 | MP0003878_abnormal_ear_physiology | 0.78790992 |
| 139 | MP0001485_abnormal_pinna_reflex | 0.78771340 |
| 140 | MP0003119_abnormal_digestive_system | 0.78511507 |
| 141 | MP0002069_abnormal_eating/drinking_beha | 0.78510255 |
| 142 | MP0002233_abnormal_nose_morphology | 0.78339783 |
| 143 | MP0005319_abnormal_enzyme/_coenzyme | 0.77192433 |
| 144 | MP0005451_abnormal_body_composition | 0.76431645 |
| 145 | MP0003755_abnormal_palate_morphology | 0.76169460 |
| 146 | MP0000920_abnormal_myelination | 0.75639970 |
| 147 | MP0003633_abnormal_nervous_system | 0.75452803 |
| 148 | MP0000383_abnormal_hair_follicle | 0.74630383 |
| 149 | MP0005409_darkened_coat_color | 0.73968648 |
| 150 | MP0002229_neurodegeneration | 0.72858178 |
| 151 | MP0005253_abnormal_eye_physiology | 0.72631778 |
| 152 | MP0008961_abnormal_basal_metabolism | 0.71595845 |
| 153 | MP0002102_abnormal_ear_morphology | 0.70774786 |
| 154 | MP0002081_perinatal_lethality | 0.70757223 |
| 155 | MP0003705_abnormal_hypodermis_morpholog | 0.67785398 |
| 156 | MP0005266_abnormal_metabolism | 0.66779118 |
| 157 | MP0004272_abnormal_basement_membrane | 0.66062214 |
| 158 | MP0000767_abnormal_smooth_muscle | 0.63820062 |
| 159 | MP0005360_urolithiasis | 0.60942003 |
| 160 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59848105 |
| 161 | MP0002295_abnormal_pulmonary_circulatio | 0.59845888 |
| 162 | MP0008874_decreased_physiological_sensi | 0.59337037 |
| 163 | MP0002108_abnormal_muscle_morphology | 0.57610540 |
| 164 | MP0002925_abnormal_cardiovascular_devel | 0.54524354 |
| 165 | MP0009840_abnormal_foam_cell | 0.51493336 |
| 166 | MP0005595_abnormal_vascular_smooth | 0.49924560 |
| 167 | MP0005187_abnormal_penis_morphology | 0.49908716 |
| 168 | MP0002138_abnormal_hepatobiliary_system | 0.47735439 |
| 169 | MP0009643_abnormal_urine_homeostasis | 0.47609088 |
| 170 | MP0002078_abnormal_glucose_homeostasis | 0.46869931 |
| 171 | MP0010678_abnormal_skin_adnexa | 0.46854745 |
| 172 | MP0003806_abnormal_nucleotide_metabolis | 0.46336690 |
| 173 | MP0005332_abnormal_amino_acid | 0.46167149 |
| 174 | MP0002971_abnormal_brown_adipose | 0.45948476 |
| 175 | MP0003191_abnormal_cellular_cholesterol | 0.45818701 |
| 176 | MP0005535_abnormal_body_temperature | 0.45641169 |
| 177 | MP0002118_abnormal_lipid_homeostasis | 0.45555492 |
| 178 | MP0000249_abnormal_blood_vessel | 0.44913779 |
| 179 | MP0001958_emphysema | 0.40668026 |
| 180 | MP0005083_abnormal_biliary_tract | 0.40656329 |
| 181 | MP0008875_abnormal_xenobiotic_pharmacok | 0.38881921 |
| 182 | MP0000003_abnormal_adipose_tissue | 0.38256722 |
| 183 | MP0005365_abnormal_bile_salt | 0.37988517 |
| 184 | MP0001614_abnormal_blood_vessel | 0.37646637 |
| 185 | MP0009115_abnormal_fat_cell | 0.36966985 |
| 186 | MP0003303_peritoneal_inflammation | 0.36512228 |
| 187 | MP0003075_altered_response_to | 0.36420014 |
| 188 | MP0010329_abnormal_lipoprotein_level | 0.35939351 |
| 189 | MP0004859_abnormal_synaptic_plasticity | 0.35320268 |
| 190 | MP0001765_abnormal_ion_homeostasis | 0.33627413 |
| 191 | MP0004147_increased_porphyrin_level | 0.31043774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.97447627 |
| 2 | Ventricular tachycardia (HP:0004756) | 6.95191129 |
| 3 | Muscle fiber splitting (HP:0003555) | 6.00030091 |
| 4 | Atrial fibrillation (HP:0005110) | 5.99680791 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 5.88966882 |
| 6 | Myokymia (HP:0002411) | 5.76111333 |
| 7 | Primary atrial arrhythmia (HP:0001692) | 5.63153779 |
| 8 | Supraventricular tachycardia (HP:0004755) | 5.43975654 |
| 9 | Supraventricular arrhythmia (HP:0005115) | 5.36286584 |
| 10 | Exercise-induced myalgia (HP:0003738) | 5.30414454 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 5.28532525 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.24523374 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 5.22435588 |
| 14 | Lipoatrophy (HP:0100578) | 5.03410669 |
| 15 | Syncope (HP:0001279) | 4.90531906 |
| 16 | Abnormality of the calf musculature (HP:0001430) | 4.82789451 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 4.76697473 |
| 18 | Bundle branch block (HP:0011710) | 4.63570005 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.49913783 |
| 20 | Subaortic stenosis (HP:0001682) | 4.49913783 |
| 21 | Palpitations (HP:0001962) | 4.48923729 |
| 22 | Myoglobinuria (HP:0002913) | 4.30983687 |
| 23 | Prolonged QT interval (HP:0001657) | 4.26784100 |
| 24 | Dilated cardiomyopathy (HP:0001644) | 4.18724546 |
| 25 | Atrioventricular block (HP:0001678) | 4.13907895 |
| 26 | Increased connective tissue (HP:0009025) | 4.10798669 |
| 27 | Heart block (HP:0012722) | 4.02828058 |
| 28 | EMG: myopathic abnormalities (HP:0003458) | 4.02715716 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 4.01939179 |
| 30 | Ventricular arrhythmia (HP:0004308) | 3.98715957 |
| 31 | Entropion (HP:0000621) | 3.97077348 |
| 32 | Goiter (HP:0000853) | 3.90109434 |
| 33 | Ventricular fibrillation (HP:0001663) | 3.82591538 |
| 34 | Difficulty running (HP:0009046) | 3.78404375 |
| 35 | Abnormal atrioventricular conduction (HP:0005150) | 3.74049101 |
| 36 | Focal motor seizures (HP:0011153) | 3.52426220 |
| 37 | Poikiloderma (HP:0001029) | 3.45813267 |
| 38 | Rhabdomyolysis (HP:0003201) | 3.25671890 |
| 39 | Type II lissencephaly (HP:0007260) | 3.21094730 |
| 40 | Myotonia (HP:0002486) | 3.16895570 |
| 41 | Difficulty climbing stairs (HP:0003551) | 3.16151765 |
| 42 | Focal seizures (HP:0007359) | 3.15593364 |
| 43 | Abnormal EKG (HP:0003115) | 3.10338368 |
| 44 | Testicular atrophy (HP:0000029) | 2.91486248 |
| 45 | Abnormality of DNA repair (HP:0003254) | 2.79140849 |
| 46 | Ketoacidosis (HP:0001993) | 2.75451767 |
| 47 | Abnormality of the aortic arch (HP:0012303) | 2.71762221 |
| 48 | Action tremor (HP:0002345) | 2.67056637 |
| 49 | Cerebellar dysplasia (HP:0007033) | 2.66997946 |
| 50 | Pili torti (HP:0003777) | 2.64158756 |
| 51 | Poor suck (HP:0002033) | 2.63336140 |
| 52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.62253756 |
| 53 | Papilledema (HP:0001085) | 2.58366943 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.56607823 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.54113410 |
| 56 | Left ventricular hypertrophy (HP:0001712) | 2.49334299 |
| 57 | Epileptic encephalopathy (HP:0200134) | 2.48769371 |
| 58 | Retinal dysplasia (HP:0007973) | 2.47185795 |
| 59 | Ketosis (HP:0001946) | 2.46628797 |
| 60 | Palmoplantar keratoderma (HP:0000982) | 2.45215867 |
| 61 | Limb-girdle muscle atrophy (HP:0003797) | 2.43638726 |
| 62 | Hepatic necrosis (HP:0002605) | 2.42799732 |
| 63 | Abnormality of midbrain morphology (HP:0002418) | 2.42161095 |
| 64 | Molar tooth sign on MRI (HP:0002419) | 2.42161095 |
| 65 | Dysmetric saccades (HP:0000641) | 2.41181980 |
| 66 | Abnormality of the labia minora (HP:0012880) | 2.40548257 |
| 67 | Spastic gait (HP:0002064) | 2.40029286 |
| 68 | Distal lower limb amyotrophy (HP:0008944) | 2.38625765 |
| 69 | Polycythemia (HP:0001901) | 2.37093674 |
| 70 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 2.36618835 |
| 71 | Lissencephaly (HP:0001339) | 2.36257837 |
| 72 | Drooling (HP:0002307) | 2.35409276 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.35364275 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.35364275 |
| 75 | Poor eye contact (HP:0000817) | 2.32677330 |
| 76 | Type 2 muscle fiber atrophy (HP:0003554) | 2.32055403 |
| 77 | Amblyopia (HP:0000646) | 2.30193368 |
| 78 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.30045858 |
| 79 | Atonic seizures (HP:0010819) | 2.29330440 |
| 80 | Abnormality of the corticospinal tract (HP:0002492) | 2.27300870 |
| 81 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.26247902 |
| 82 | Areflexia of lower limbs (HP:0002522) | 2.24799422 |
| 83 | Polyphagia (HP:0002591) | 2.24779049 |
| 84 | Sudden cardiac death (HP:0001645) | 2.24317125 |
| 85 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.24198017 |
| 86 | Short 4th metacarpal (HP:0010044) | 2.24198017 |
| 87 | Abnormal social behavior (HP:0012433) | 2.21437935 |
| 88 | Impaired social interactions (HP:0000735) | 2.21437935 |
| 89 | Urinary urgency (HP:0000012) | 2.18185113 |
| 90 | Broad metatarsal (HP:0001783) | 2.16667536 |
| 91 | Gait imbalance (HP:0002141) | 2.16161325 |
| 92 | Hypoplasia of the brainstem (HP:0002365) | 2.15674059 |
| 93 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.15674059 |
| 94 | Anomalous pulmonary venous return (HP:0010772) | 2.15320579 |
| 95 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.14008840 |
| 96 | Nephronophthisis (HP:0000090) | 2.12816131 |
| 97 | Cerebral edema (HP:0002181) | 2.12790635 |
| 98 | Muscle stiffness (HP:0003552) | 2.12254395 |
| 99 | Abnormality of the foot musculature (HP:0001436) | 2.10901209 |
| 100 | Oligodactyly (hands) (HP:0001180) | 2.10783272 |
| 101 | Sleep apnea (HP:0010535) | 2.10447544 |
| 102 | Abnormality of the lower motor neuron (HP:0002366) | 2.09804527 |
| 103 | Oligodactyly (HP:0012165) | 2.09134241 |
| 104 | Abnormal eating behavior (HP:0100738) | 2.08547369 |
| 105 | Increased muscle lipid content (HP:0009058) | 2.08377840 |
| 106 | Confusion (HP:0001289) | 2.08072456 |
| 107 | Excessive salivation (HP:0003781) | 2.07023478 |
| 108 | Pachygyria (HP:0001302) | 2.06880115 |
| 109 | Severe muscular hypotonia (HP:0006829) | 2.06224536 |
| 110 | Ankle clonus (HP:0011448) | 2.03721898 |
| 111 | Acute necrotizing encephalopathy (HP:0006965) | 2.03062689 |
| 112 | Absent speech (HP:0001344) | 2.02847349 |
| 113 | Muscle fiber atrophy (HP:0100295) | 2.02621890 |
| 114 | Foot dorsiflexor weakness (HP:0009027) | 2.02562292 |
| 115 | Hepatocellular necrosis (HP:0001404) | 2.02118003 |
| 116 | Ragged-red muscle fibers (HP:0003200) | 2.01248942 |
| 117 | EMG: neuropathic changes (HP:0003445) | 2.00843167 |
| 118 | Hyperammonemia (HP:0001987) | 2.00754633 |
| 119 | Respiratory distress (HP:0002098) | 1.99460252 |
| 120 | Occipital encephalocele (HP:0002085) | 1.97556766 |
| 121 | Renal dysplasia (HP:0000110) | 1.96103479 |
| 122 | Febrile seizures (HP:0002373) | 1.95477560 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94908460 |
| 124 | Congestive heart failure (HP:0001635) | 1.94607996 |
| 125 | Abnormality of the 4th metacarpal (HP:0010012) | 1.94085987 |
| 126 | Lymphangioma (HP:0100764) | 1.94050426 |
| 127 | Generalized tonic-clonic seizures (HP:0002069) | 1.93152271 |
| 128 | Palpebral edema (HP:0100540) | 1.92887323 |
| 129 | Hypoventilation (HP:0002791) | 1.90023359 |
| 130 | Labial hypoplasia (HP:0000066) | 1.88559577 |
| 131 | Abnormality of the pulmonary veins (HP:0011718) | 1.88264850 |
| 132 | Acute encephalopathy (HP:0006846) | 1.88181784 |
| 133 | Lower limb amyotrophy (HP:0007210) | 1.87887918 |
| 134 | Turricephaly (HP:0000262) | 1.86573022 |
| 135 | Diaphragmatic weakness (HP:0009113) | 1.86559736 |
| 136 | Facial diplegia (HP:0001349) | 1.86172472 |
| 137 | Progressive cerebellar ataxia (HP:0002073) | 1.85002405 |
| 138 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.84832602 |
| 139 | Neck muscle weakness (HP:0000467) | 1.83818631 |
| 140 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.83061083 |
| 141 | Cerebral hypomyelination (HP:0006808) | 1.82799505 |
| 142 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.81794349 |
| 143 | Large for gestational age (HP:0001520) | 1.80144440 |
| 144 | Decreased muscle mass (HP:0003199) | 1.77518492 |
| 145 | Cerebral hemorrhage (HP:0001342) | 1.76600651 |
| 146 | Muscular dystrophy (HP:0003560) | 1.76513273 |
| 147 | Medial flaring of the eyebrow (HP:0010747) | 1.74876586 |
| 148 | Visual hallucinations (HP:0002367) | 1.74089010 |
| 149 | Cholelithiasis (HP:0001081) | 1.73710937 |
| 150 | Narrow nasal bridge (HP:0000446) | 1.73551990 |
| 151 | Hyperglycinuria (HP:0003108) | 1.73520648 |
| 152 | Failure to thrive in infancy (HP:0001531) | 1.73087380 |
| 153 | Double outlet right ventricle (HP:0001719) | 1.72842962 |
| 154 | Congenital malformation of the right heart (HP:0011723) | 1.72842962 |
| 155 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.72496815 |
| 156 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.71195528 |
| 157 | Narrow forehead (HP:0000341) | 1.70690811 |
| 158 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.70288582 |
| 159 | Congenital primary aphakia (HP:0007707) | 1.70244620 |
| 160 | Type 1 muscle fiber predominance (HP:0003803) | 1.69957369 |
| 161 | Buphthalmos (HP:0000557) | 1.67958504 |
| 162 | Increased intramyocellular lipid droplets (HP:0012240) | 1.67784818 |
| 163 | Abnormality of the tricuspid valve (HP:0001702) | 1.67274054 |
| 164 | Annular pancreas (HP:0001734) | 1.66907459 |
| 165 | Generalized muscle weakness (HP:0003324) | 1.66622956 |
| 166 | Nephrogenic diabetes insipidus (HP:0009806) | 1.66530466 |
| 167 | Pulmonary artery stenosis (HP:0004415) | 1.66410207 |
| 168 | Mitochondrial inheritance (HP:0001427) | 1.66217261 |
| 169 | Rapidly progressive (HP:0003678) | 1.64152539 |
| 170 | Thyroid-stimulating hormone excess (HP:0002925) | 1.64140484 |
| 171 | Lactic acidosis (HP:0003128) | 1.63949801 |
| 172 | Respiratory failure (HP:0002878) | 1.63852610 |
| 173 | Abnormality of the diencephalon (HP:0010662) | 1.63724473 |
| 174 | Abnormality of lateral ventricle (HP:0030047) | 1.63666460 |
| 175 | Broad-based gait (HP:0002136) | 1.63615607 |
| 176 | Abnormality of the renal medulla (HP:0100957) | 1.63213051 |
| 177 | Intellectual disability, moderate (HP:0002342) | 1.63091449 |
| 178 | Hypoplasia of the corpus callosum (HP:0002079) | 1.62353132 |
| 179 | Dialeptic seizures (HP:0011146) | 1.61555237 |
| 180 | Facial hemangioma (HP:0000329) | 1.60613279 |
| 181 | Hypoplastic female external genitalia (HP:0012815) | 1.60487939 |
| 182 | Meningocele (HP:0002435) | 1.59227386 |
| 183 | Limb dystonia (HP:0002451) | 1.59147620 |
| 184 | Proximal amyotrophy (HP:0007126) | 1.57993220 |
| 185 | Split foot (HP:0001839) | 1.57851988 |
| 186 | Conjunctival hamartoma (HP:0100780) | 1.57820347 |
| 187 | Nonprogressive disorder (HP:0003680) | 1.56833477 |
| 188 | Cortical visual impairment (HP:0100704) | 1.55666193 |
| 189 | Shawl scrotum (HP:0000049) | 1.55506938 |
| 190 | Shallow orbits (HP:0000586) | 1.54833216 |
| 191 | Vitreoretinal degeneration (HP:0000655) | 1.54792854 |
| 192 | Cystic liver disease (HP:0006706) | 1.54406523 |
| 193 | Vaginal atresia (HP:0000148) | 1.52226813 |
| 194 | Intellectual disability, severe (HP:0010864) | 1.52070679 |
| 195 | Absence seizures (HP:0002121) | 1.51621125 |
| 196 | Genital tract atresia (HP:0001827) | 1.51377298 |
| 197 | Hypoplastic ischia (HP:0003175) | 1.50648243 |
| 198 | Wide anterior fontanel (HP:0000260) | 1.50081910 |
| 199 | Partial duplication of the phalanx of hand (HP:0009999) | 1.48974690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.64637014 |
| 2 | MARK1 | 5.18313302 |
| 3 | CASK | 3.92607938 |
| 4 | LMTK2 | 3.67730003 |
| 5 | TIE1 | 3.63208856 |
| 6 | PHKG2 | 3.40926063 |
| 7 | PHKG1 | 3.40926063 |
| 8 | DMPK | 3.38286559 |
| 9 | MYLK | 3.37304773 |
| 10 | NTRK2 | 3.13225312 |
| 11 | PDK3 | 2.87047995 |
| 12 | PDK4 | 2.87047995 |
| 13 | PKN2 | 2.69639404 |
| 14 | OBSCN | 2.63851456 |
| 15 | TRIB3 | 2.62483584 |
| 16 | SIK2 | 2.55437144 |
| 17 | BCKDK | 2.38336155 |
| 18 | NTRK1 | 2.37064777 |
| 19 | MAP3K9 | 2.22155707 |
| 20 | NEK1 | 2.01721720 |
| 21 | KDR | 1.96861993 |
| 22 | DYRK2 | 1.94173393 |
| 23 | EPHB2 | 1.66049165 |
| 24 | PDK2 | 1.65817722 |
| 25 | TNIK | 1.65559521 |
| 26 | MAPK13 | 1.63668451 |
| 27 | TYRO3 | 1.62260219 |
| 28 | EPHA4 | 1.59967355 |
| 29 | MINK1 | 1.58199747 |
| 30 | CAMK1G | 1.55841412 |
| 31 | PAK3 | 1.54841763 |
| 32 | PIK3CA | 1.52938906 |
| 33 | SGK223 | 1.45322056 |
| 34 | SGK494 | 1.45322056 |
| 35 | PNCK | 1.43320736 |
| 36 | MUSK | 1.39834478 |
| 37 | MAP3K4 | 1.37828392 |
| 38 | PRKD1 | 1.37524540 |
| 39 | MAP3K7 | 1.35454514 |
| 40 | CAMK1D | 1.33724651 |
| 41 | UHMK1 | 1.33554302 |
| 42 | PTK2B | 1.28850503 |
| 43 | PINK1 | 1.27602206 |
| 44 | DYRK1A | 1.26441466 |
| 45 | RIPK1 | 1.23624084 |
| 46 | EPHB1 | 1.20411155 |
| 47 | CAMK2D | 1.19884653 |
| 48 | CDC42BPA | 1.18223694 |
| 49 | MAP2K3 | 1.16830642 |
| 50 | CDK5 | 1.13498991 |
| 51 | PRKCG | 1.11536040 |
| 52 | MAP2K7 | 1.11501911 |
| 53 | MAP2K4 | 1.05486792 |
| 54 | CAMKK1 | 1.05485086 |
| 55 | FGFR2 | 1.01997862 |
| 56 | KSR1 | 1.00533198 |
| 57 | STK24 | 0.99868052 |
| 58 | SGK2 | 0.99709823 |
| 59 | STK38 | 0.99688686 |
| 60 | INSRR | 0.99352752 |
| 61 | STK16 | 0.97929406 |
| 62 | PRKCZ | 0.97578806 |
| 63 | CAMK2B | 0.95472133 |
| 64 | WNK3 | 0.94419713 |
| 65 | GRK7 | 0.94216652 |
| 66 | MAPK12 | 0.91647031 |
| 67 | WNK4 | 0.91349955 |
| 68 | PRKAA2 | 0.90711818 |
| 69 | ROCK1 | 0.89736910 |
| 70 | DAPK3 | 0.88831093 |
| 71 | CDK19 | 0.88759953 |
| 72 | FER | 0.88705813 |
| 73 | MAP3K5 | 0.85727990 |
| 74 | RPS6KA2 | 0.85559249 |
| 75 | STK4 | 0.83322609 |
| 76 | DYRK1B | 0.82689529 |
| 77 | SIK1 | 0.81416568 |
| 78 | TAOK1 | 0.80711229 |
| 79 | FGFR4 | 0.80406707 |
| 80 | PRKD3 | 0.80094580 |
| 81 | TGFBR2 | 0.78740491 |
| 82 | RET | 0.78100905 |
| 83 | ICK | 0.77197011 |
| 84 | TGFBR1 | 0.75443857 |
| 85 | CAMKK2 | 0.75251828 |
| 86 | CAMK4 | 0.73581082 |
| 87 | PTK6 | 0.73067870 |
| 88 | PRKAA1 | 0.72133033 |
| 89 | ROCK2 | 0.72014869 |
| 90 | CDK11A | 0.71465945 |
| 91 | CDK15 | 0.71102911 |
| 92 | ILK | 0.70313822 |
| 93 | CDK18 | 0.68910887 |
| 94 | LIMK1 | 0.68125029 |
| 95 | CAMK2A | 0.66296902 |
| 96 | SGK3 | 0.66248489 |
| 97 | RPS6KC1 | 0.65837159 |
| 98 | RPS6KL1 | 0.65837159 |
| 99 | DAPK2 | 0.65367643 |
| 100 | ALK | 0.64341353 |
| 101 | WNK1 | 0.62924845 |
| 102 | MARK2 | 0.62122382 |
| 103 | CDK14 | 0.61420138 |
| 104 | PKN1 | 0.60828578 |
| 105 | ADRBK2 | 0.60442602 |
| 106 | CAMK1 | 0.60118021 |
| 107 | TRPM7 | 0.60114841 |
| 108 | FLT3 | 0.58782557 |
| 109 | PLK2 | 0.58108323 |
| 110 | CSNK1G2 | 0.57897042 |
| 111 | RPS6KA6 | 0.57244989 |
| 112 | PDGFRA | 0.56264237 |
| 113 | JAK1 | 0.56229519 |
| 114 | MAP3K6 | 0.56138347 |
| 115 | PDPK1 | 0.55292779 |
| 116 | STK11 | 0.54142872 |
| 117 | ERN1 | 0.52808940 |
| 118 | ERBB2 | 0.52329367 |
| 119 | MAPK10 | 0.51805397 |
| 120 | LRRK2 | 0.51647948 |
| 121 | PRKACB | 0.50731217 |
| 122 | TESK1 | 0.49602221 |
| 123 | NTRK3 | 0.49106017 |
| 124 | PRKACG | 0.49009637 |
| 125 | PRKCE | 0.47260623 |
| 126 | CDK9 | 0.45896354 |
| 127 | KSR2 | 0.45296636 |
| 128 | PDK1 | 0.44934810 |
| 129 | GRK1 | 0.44261738 |
| 130 | PRKCH | 0.43118374 |
| 131 | RPS6KA3 | 0.42810053 |
| 132 | CSNK1E | 0.42602625 |
| 133 | PRKG2 | 0.42442850 |
| 134 | RPS6KB1 | 0.42192739 |
| 135 | MAP3K1 | 0.41752478 |
| 136 | MAP3K11 | 0.41547048 |
| 137 | DDR2 | 0.41282365 |
| 138 | BCR | 0.40238534 |
| 139 | MAP3K3 | 0.39705486 |
| 140 | BLK | 0.39503731 |
| 141 | MET | 0.39040170 |
| 142 | PRKACA | 0.38408233 |
| 143 | MAPKAPK3 | 0.35171898 |
| 144 | STK38L | 0.34084466 |
| 145 | JAK2 | 0.33476914 |
| 146 | PAK6 | 0.32889372 |
| 147 | PRKCQ | 0.31538971 |
| 148 | MTOR | 0.28911585 |
| 149 | ZAK | 0.28771578 |
| 150 | FES | 0.28143744 |
| 151 | SGK1 | 0.28132328 |
| 152 | MAP2K6 | 0.27608309 |
| 153 | TYK2 | 0.25828126 |
| 154 | CLK1 | 0.25470869 |
| 155 | MAP3K13 | 0.25232676 |
| 156 | CAMK2G | 0.24768646 |
| 157 | PDGFRB | 0.24109845 |
| 158 | PTK2 | 0.22979507 |
| 159 | PRKD2 | 0.22872579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.87774407 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.40616627 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.08592292 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.62115812 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.61125816 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.33768533 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.13628289 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.84993417 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.79579577 |
| 10 | Cocaine addiction_Homo sapiens_hsa05030 | 2.56530111 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.42059625 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.27795330 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.24073529 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.15389631 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 2.15314659 |
| 16 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.14200562 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.08463038 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 2.00372518 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00316134 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.95780800 |
| 21 | Axon guidance_Homo sapiens_hsa04360 | 1.92235888 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.89598665 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86211941 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.84766913 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.79489325 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70252324 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.69774923 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.66009508 |
| 29 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.65498886 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58251682 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.55913321 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.46057777 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44048332 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.42701351 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39420380 |
| 36 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.35092265 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34338230 |
| 38 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.31584213 |
| 39 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.28253450 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28058168 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.27206350 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.26628726 |
| 43 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.24329260 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.24027177 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23233434 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20416836 |
| 47 | Gap junction_Homo sapiens_hsa04540 | 1.14550114 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13605951 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12014714 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09943494 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09682642 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 1.08335772 |
| 53 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.05538547 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 1.04100695 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 1.00064340 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.98450293 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97909358 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97183538 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96406597 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93761416 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91624542 |
| 62 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.91519001 |
| 63 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91440060 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.89603315 |
| 65 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.84338039 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83870777 |
| 67 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81909109 |
| 68 | Long-term depression_Homo sapiens_hsa04730 | 0.81036633 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.80249230 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78399778 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75842749 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74955119 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73866161 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72748331 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71852833 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71667980 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71160156 |
| 78 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70591968 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68619659 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67448780 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66930002 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66507527 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.66398631 |
| 84 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65900253 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65891427 |
| 86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64859772 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64416585 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63359152 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62239657 |
| 90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61753316 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60948902 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.59275791 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59009478 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58794905 |
| 95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58700469 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.58648668 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.58456560 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57456447 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.56704940 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55396618 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55345404 |
| 102 | Peroxisome_Homo sapiens_hsa04146 | 0.54742549 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54376708 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54005554 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53661436 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53067233 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52932978 |
| 108 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52601712 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49179010 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44599547 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44196070 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43967047 |
| 113 | Insulin secretion_Homo sapiens_hsa04911 | 0.43804381 |
| 114 | Melanoma_Homo sapiens_hsa05218 | 0.43803837 |
| 115 | Ribosome_Homo sapiens_hsa03010 | 0.43719458 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43350947 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42531649 |
| 118 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41693089 |
| 119 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39143275 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38657868 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.37522487 |
| 122 | Tight junction_Homo sapiens_hsa04530 | 0.36478308 |
| 123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36184640 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35663669 |
| 125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35033173 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34604205 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32737242 |
| 128 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31579327 |
| 129 | Morphine addiction_Homo sapiens_hsa05032 | 0.31397630 |
| 130 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31271608 |
| 131 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30222136 |
| 132 | Salivary secretion_Homo sapiens_hsa04970 | 0.28383475 |
| 133 | Taste transduction_Homo sapiens_hsa04742 | 0.26959982 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26909740 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25445788 |
| 136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24486719 |
| 137 | Mineral absorption_Homo sapiens_hsa04978 | 0.24414359 |
| 138 | Long-term potentiation_Homo sapiens_hsa04720 | 0.24256330 |
| 139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23195587 |
| 140 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.22132319 |
| 141 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.21399552 |
| 142 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18466501 |
| 143 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.17180437 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16407186 |
| 145 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.16356434 |
| 146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.14748232 |
| 147 | Olfactory transduction_Homo sapiens_hsa04740 | 0.14419372 |
| 148 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.14246699 |

